Offer - Urjas Oil for just ₹ 1 X
Winogem is a prescription drug, available for use as Injection. It is typically used for the treatment of Pancreatic Cancer, Non-Small Cell Lung Cancer. Other than this, Winogem has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Winogem. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Winogem as well, which are listed below. These side effects of Winogem are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Winogem has a Unknown effect for pregnant women and Severe effect on lactating mothers. It is important to know if Winogem has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Winogem related warnings section.
Winogem is contraindicated in people with pre-existing medical conditions like Heart Disease, Infections as it can result in adverse effects. The section on Winogem contraindications lists all such conditions.
Drug reaction of Winogem with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Winogem is safe while driving, and is is addictive in nature.
Winogem is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Adult |
|
Geriatric |
|
Is the use of Winogem safe for pregnant women?
The effects of Winogem on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Winogem safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Winogem. It should only be taken after medical advice.
What is the effect of Winogem on the Kidneys?
Winogem has very mild side effects on the kidneys.
What is the effect of Winogem on the Liver?
The liver can be affected by Winogem. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Winogem only after medical advice.
What is the effect of Winogem on the Heart?
Winogem is rarely harmful for the heart.
Winogem should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Winogem unless your doctor advises you to do so -
Is this Winogem habit forming or addictive?
Forming a habit of Winogem has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Winogem will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Winogem is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Winogem in mental disorders is not effective.
Interaction between Food and Winogem
Due to a lack of research, nothing can be said about the consequences of taking Winogem together with food.
Interaction between Alcohol and Winogem
No research has been done on this till date. Therefore, it is not known what the effect of taking Winogem with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gemzar® (Gemcitabine HCl)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 612-614